| Stage | FENC | % of rev | AMGN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $18M | 100.00% | $10.1B | 100.00% | AMGN ×562.49 |
| Gross profit | $17M | 95.97% | $7.2B | 72.04% | FENC +23.9pp |
| Operating income | $2M | 9.72% | $3.5B | 34.95% | AMGN +25.2pp |
| Pre-tax income | $2M | 11.27% | $2.8B | 27.53% | AMGN +16.3pp |
| Net income | $2M | 11.04% | $2.4B | 23.62% | AMGN +12.6pp |
| Stage | FENC | AMGN | Gap · A − B |
|---|---|---|---|
| Revenue | $18M100.00% | $10.1B100.00% | AMGN ×562.49 |
| Gross profit | 95.97%$17M | 72.04%$7.2B | FENC +23.9pp |
| Operating income | 9.72%$2M | 34.95%$3.5B | AMGN +25.2pp |
| Pre-tax income | 11.27%$2M | 27.53%$2.8B | AMGN +16.3pp |
| Net income |
| 11.04%$2M |
| 23.62%$2.4B |
| AMGN +12.6pp |
No shared counterparties.